Duke-NUS celebrates 20 years of medical innovation with largest ever graduating class
Landmark first batch of Masters in Patient Safety and Healthcare Quality graduates, unique to Southeast Asia
Inaugural graduates from conditional admissions pathways with NUS and SUTD
41% of MD and MD-PhD graduates made bold mid-career shifts from fields such as law, PR, accounting and mental health support
SINGAPORE, May 31, 2025 /PRNewswire/ — Celebrating 20 years of transformative medical education, Duke-NUS Medical School graduated its largest cohort yet today, the Class of 2025, in a vibrant ceremony at the Ngee Ann Kongsi Auditorium in Academia attended by guest-of-honour Mr Ong Ye Kung, Minister for Health.
Marking a strategic milestone for Duke-NUS, the graduating class included 72 Doctor of Medicine (MD) graduates—five of whom are also earning PhDs—and 27 PhD candidates from the Integrated Biology and Medicine, Quantitative Biology and Medicine and Clinical and Translational Sciences programmes.
Among the MD graduates was the first group of individuals emerging from the Duke-NUS conditional admissions pathways with the National University of Singapore (NUS) and the Singapore University of Technology and Design (SUTD). These pathways are designed to attract talent from engineering, information technology and other undergraduate programmes.
Dean Professor Thomas Coffman said: 'Collaborating with seven partner universities, including Duke University and NUS, these pathways are designed to allow students to earn a first degree in diverse academic majors while providing an opportunity to seamlessly transition into medicine. It's a powerful model for developing doctors who are outstanding clinicians but also bring valuable multi-disciplinary skills into our healthcare system.'
This cohort also includes the inaugural batch of graduates of the Master's in Patient Safety and Healthcare Quality (MPSHQ) programme, the first of its kind in Southeast Asia. The MPSHQ is focused on building highly reliable healthcare systems that are of consistent quality and safety.
The Class of 2025 represents Duke-NUS' commitment to broadening the skillset and experience of our students, with 41 per cent of MD and MD-PhD graduates having transitioned mid-career from professions that include law, public relations, accounting and mental health peer support. Additionally, 58 per cent of the Class of 2025's graduates are women, underscoring the School's dedication to fostering diversity in the learning environment.
Said Dr Faith Wong Pih Yng, previously a modelmaking student and senior peer support specialist at Singapore's Institute of Mental Health, now MD graduate, 'Among the many hospital postings, what stood out most vividly was assisting in and witnessing childbirth—the intense anticipation and joy of welcoming a new life into the world was simply unmatched. Ultimately, however, the memories I cherish most are the countless hours spent with my classmates, supporting one another and peer-teaching.'
Duke-NUS MD graduates received their degrees, awarded jointly by Duke University and the National University of Singapore, in front of friends and family, as well as notable guests, including Duke University School of Medicine Dean Professor Mary Klotman, SingHealth Group CEO Professor Ng Wai Hoe, and keynote speaker, Dr Amy Abernethy, member of Duke University's board of trustees and co-founder of Highlander Health.
Caring and compassion underlines the Class of 2025's accomplishments, especially beyond academia. Partaking in a wealth of community service projects, some of their cohort, such as Dr Dana Chow Wai Shin, MD, started the Healthy to Thrive initiative, the first Duke-NUS-led public health screening event dedicated to migrant workers.
The cohort was also recognised for their outstanding achievements, which were given out the night before. Awards such as the Singapore Medical Association-Lee Foundation Prizes and Teamsmanship Awards presented to graduates who demonstrated excellence in academics, community service, and leadership.
In the aspect of research and scholarship, the Class of 2025 did not flag, publishing an exceptional 253 papers and publications in their time at Duke-NUS, several as first authors in prominent journals such as Nature Medicine, Immunity and EMBO Molecular Medicine. MD-PhD graduate Dr Katherine Nay Yaung, first author on a paper published in Lancet Rheumatology, wrote about artificial intelligence and high-dimensional technologies to diagnose and treat autoimmune diseases, and PhD graduate Dr Aishwarya Prakash, named first author and published in American Heart Association Journal, who found a type of peptide to have protective qualities for the heart after sustaining damage.
'The conversations I've had with patients emphasise a shift towards continuity of care and empowering individuals to make their own health choices. In moments where I feel overwhelmed, I remind myself that being a small part of each patient's journey has been a privilege,' said Dr Pang Wui Ming Jeremy, recipient of the SingHealth Prize in Family Medicine, Singapore Medical Association-Lee Foundation Teamsmanship Award for exemplary team values in medicine and Duke-NUS Achievement Prize.
As Duke-NUS enters its third decade, the School continues to redefine medical education and research, nurturing the next generation of healthcare leaders who are not just exceptional doctors but visionary innovators ready to make an impact in Singapore and beyond.
About Duke-NUS Medical School
Duke-NUS is Singapore's flagship graduate-entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five Signature Research Programmes and ten Centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has led to the creation of 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.
For more information, please visit www.duke-nus.edu.sg
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
31-07-2025
- Malay Mail
Johor MB raises healthcare worker recruitment concerns with Singapore minister in bilateral meet
SNGAPORE, July 31 — Johor Menteri Besar Datuk Onn Hafiz Ghazi said he raised the issue of the republic's reported recruitment of Malaysia's healthcare workers during a meeting with Singapore Health Minister Ong Ye Kung. Onn Hafiz said he broached the topic in a 'spirit of openness,' and as part of larger discussions on public health systems, challenges of healthcare workforce shortages, and measures to increase health awareness among the people. 'We agreed that as two neighbouring countries sharing close relationships and mutual respect, any workforce mobility initiatives should be implemented through official channels and structured, transparent bilateral cooperation frameworks,' he said in a statement. In a meeting held in Orchard, the two leaders also explored potential collaboration under the Johor-Singapore Special Economic Zone (JS-SEZ), particularly in medical technology, healthcare investment, medical tourism, and talent development. Both sides stressed the need for data-sharing and exchange of best practices to help build more inclusive and responsive healthcare systems. Onn Hafiz expressed confidence that the meeting would lay the foundation for a more sustainable and comprehensive health partnership to improve services and access for the people of Johor. Earlier this month, Singapore's Ministry of Health directly interviewed Malaysian doctors and general practitioners at Traders Hotel KLCC as part of its move to strengthen its healthcare workforce. The recruitment drive offers a starting salary of S$110,000 (about RM385,000) per year, excluding monthly accommodation allowance, insurance and other benefits. This prompted Health Minister Datuk Seri Dr Dzulkefly Ahmad to say his ministry is implementing various measures to encourage healthcare workers to stay, including expediting permanent position appointments among contract doctors.
The Star
20-07-2025
- The Star
One in three vapes in Singapore laced with etomidate; Health Ministry working with Home Affairs Ministry to list it as illegal drug: Health Minister Ong
SINGAPORE: The authorities are working to list etomidate, which is being abused via e-vaporisers, under the Misuse of Drugs Act (MDA), Health Minister Ong Ye Kung said on Sunday (July 20). This paves the way for abusers and traffickers of Kpods – vapes containing etomidate – to be treated in the same way as those who abuse or traffic drugs like nimetazepam, also known as Erimin-5, with mandatory rehabilitation and jail time for repeat offenders. Currently, etomidate is listed under the Poisons Act. Under this law, abusers face only a fine. Sellers face possible jail time of up to two years. But with the growing trend of e-vaporisers containing the drug, Ong said it was now necessary to take stronger action. This will be done in the coming weeks, and is an interim measure till further changes can be made to the law to tackle the vaping scourge here, Ong added. The Ministry of Health is working with the Ministry of Home Affairs to do this. The move comes after one in three vapes recently seized here was found to contain etomidate. Speaking on the sidelines of the opening of a dog run in Sembawang on July 20, Ong said a third of more than 100 vapes seized during enforcement operations and tested at random were found to contain the substance. Ong said that previously, a vape would be used mainly for the delivery of nicotine. 'But today, it is a delivery device for a range of substances, from nicotine to psychoactive substances such as etomidate, to hardcore drugs that are illegal under the MDA as well,' he said. 'When that is the situation, it requires a whole of government effort to enforce against this.' Etomidate is a medicinal ingredient used in clinical practice as an anaesthetic agent and is classified as a poison under the Poisons Act. It was designed to be injected directly into the veins under clinical supervision and was never meant to be inhaled directly into the lungs. When vaped, it can trigger spasms, breathing difficulties, seizures and psychosis. Health Minister Ong Ye Kung said a third of more than 100 vapes seized during enforcement operations and tested at random were found to contain etomidate. - Photo: Lianhe Zaobao Ong confirmed that several deaths here have been linked to the abuse of the substance. He said: 'We have seen some deaths, traffic accidents, as well as unnatural deaths, where etomidate is implicated... it is a serious problem.' Listing etomidate under the MDA will mean abusers will be subject to supervision, and may be committed to a drug rehabilitation centre, he said. Ong urged those who are using Kpods to stop immediately. He said: 'I urge those who are consuming etomidate-laced vapes, give it up now, before the law catches up with you. It is very harmful, and the time to give up is now.' He added that a big challenge in dealing with vapes is the attitude towards it, with vapes having been successfully marketed by vape makers to young people as harmless and trendy. 'It's actually unconscionable,' he said. 'We are up against a mindset that might have set in among some young people, and we now need to counter that.' In a separate update on July 20, the Health Sciences Authority (HSA) said it will be extending the hours for its reporting hotline. Previously, HSA's Tobacco Regulation Branch could be reached only from 9am to 5.30pm on weekdays. But the hotline service to report vaping-related offences will be expanded to operate seven days a week, with extended hours from 9am to 9pm, HSA said. ST launched its anti-vaping campaign, Vaping: The Invisible Crisis, on July 13. Ong said of the initiative at the July 20 event: 'The Straits Times is on a useful campaign, in my view, to raise awareness about the harmfulness of etomidate, and also to urge agencies to step up actions. Many members of the public have done likewise.' When ST launched the campaign, several Telegram channels selling vapes became significantly less active. The campaign aims to raise awareness of the vape scourge. Kpods have reportedly been pushed in Singapore by organised crime groups, with local authorities now intensifying crackdowns. Public healthcare institutions have also been told to record all Kpod cases. Possessing, using or buying vapes carries a maximum fine of $2,000. Anyone who distributes, imports or sells vapes and their components can be jailed for up to six months and fined up to $10,000. Those found in possession of or using pods containing etomidate can be jailed for up to two years and fined up to $10,000. - The Straits Times/ANN
The Star
10-07-2025
- The Star
Proposed new law protecting Singaporeans' genetic data to be strengthened
SINGAPORE: The proposed new law to protect genetic data collected on Singaporeans will be strengthened to provide greater clarity on what the hereditary information can or cannot be used for. And the Ministry of Health (MOH) will be conducting broad public consultations on the topic, Health Minister Ong Ye Kung said. 'For healthcare to be delivered seamlessly across all settings, and especially in the community, a patient's data needs to be captured and shared among healthcare providers whom he sought care from,' he said. Doing so immediately raises concerns about cybersecurity, which MOH is addressing by strengthening the legislative structure, he added. The Health Minister was speaking at the 9th CHI Innovate 2025, NHG Health's flagship innovation conference, on July 10, where at the Ng Teng Fong Centre for Healthcare Innovation. Genetic screening for medical conditions of the general public is already being carried out as part of a nationwide programme to enhance preventive care in Singapore. Starting June 30, eligible Singapore residents, for instance, can be screened for familial hypercholesterolaemia (FH), a genetic condition that causes high cholesterol levels, at a subsidised rate. The initiative aims to identify individuals with FH early and reduce the risk of premature heart disease with timely interventions. To address the worries about data privacy, Ong, who is also the Coordinating Minister for Social Policies, said his ministry is coming up with a new law – the proposed Health Information Act. 'Under the Act, beyond various data protection measures, a patient can choose to restrict the sharing of his medical data among the healthcare providers that he sought care from,' he said. While this may not be an ideal arrangement and may undermine quality of care for the patient, making such a choice available addresses fears and instils confidence, he added. Ong said that when genetic data is easily available, there will be public concerns on how the data is used and whether technology 'will inadvertently push us across societal and ethical lines'. 'MOH is therefore working on enhancing legislative protections on the use of genetic test information and will be conducting broad public consultation. 'The legislation will provide greater clarity on what genetic information can be used for, such as for medical treatment, and what it cannot be used for, such as in deciding employment and insurance (coverage),' he said. Ong said beyond addressing the fears and concerns arising from technology, everyone can be empowered to participate in innovation and leverage technology to do a better job. But he warned that as digital technology revolutionises human communications, it might have also rewired the minds of a generation. 'The evidence is still being debated, but ask any psychologist or counsellor, and they will tell you stories of how smart devices, video games or social media addiction have inflicted pain on young minds,' he said. Ong said while there is no doubt artificial intelligence (AI) will have a profound impact on society, healthcare institutions need to 'use it judiciously and deploy it thoughtfully'. In employing AI, NHG Health has signed a five-year master collaboration agreement with ST Engineering to co-develop and implement engineering and smart systems to further enhance patient care and optimise health service delivery. The group also signed a memorandum of understanding with Nanyang Technological University's Lee Kong Chian School of Medicine and Hong Kong-based Cornerstone Robotics to focus on advanced research and innovation in surgical robotics systems. This alliance will identify future robotic-assisted surgery for a wider range of conditions treated at the hospitals under NHG Health and offer safer, less invasive and more affordable procedures to the patients. - The Straits Times/ANN
